MacroGenics | MGNX - Equity Capital And Reserves

Stock Price
4.35
Daily Change
0.10 2.35%
Monthly
25.00%
Yearly
173.58%
Q2 Forecast
4.16

MacroGenics reported $21.2M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -6.66B 3.39B Mar/2026
Amgen USD 9.19B 532M Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
Biogen USD 18.65B 394.9M Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Daiichi Sankyo JPY 1.71T 57.86B Dec/2025
Eli Lilly USD 31.2B 4.66B Mar/2026
Genmab DKK 5.85B 96M Dec/2025
Geron USD 229.11M 3.24M Mar/2026
Gilead Sciences USD 23.52B 897M Mar/2026
J&J USD 81.19B 358M Mar/2026
Karyopharm Therapeutics USD -292.93M 23.67M Dec/2025
MacroGenics USD 21.2M 34.39M Mar/2026
Merck USD 45.88B 6.73B Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Regeneron Pharmaceuticals USD 31.42B 166.7M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Xencor USD 515.63M 119.95M Mar/2026